Abstract

TAPIA ARRAZOLA, Dra. Use of Cystatin C as early biomarker of renal damage in patients with diabetes mellitus type 2. MEDISAN [online]. 2019, vol.23, n.3, pp.483-494.  Epub June 28, 2019. ISSN 1029-3019.

An observational, descriptive series of cases study, was carried out in 144 patients with diabetes mellitus type 2, assisted in the Clinical Laboratory of Saturnino Lora Torres Teaching Provincial Hospital in Santiago de Cuba from May, 2017 to the same month of 2018, who were from the Endocrinology Service of the same hospital, with the aim of evaluating the utility of the Cystatin C as early biomarker of renal damage. Patients older than 50 years of age and female sex, besides hypertension as associated disease and the outlying neuropathy as complication prevailed in the investigation. It was concluded that Cystatin C is useful as early biomarker of renal damage in patients with diabetes mellitus type 2, fundamentally if there are comorbidities and complications that could cause chronic renal failure, which can be prevented.

Keywords : diabetes mellitus type 2; chronic renal disease; serum creatinine; glomerular filtrate; Cystatin C.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )